CrowdStrike slumps more than 6% on weak earnings outlook, overhang from outage costs

Ad

Somaderm


In this article

  • CRWD

Follow your favorite stocksCREATE FREE ACCOUNTCrowdStrike CEO George Kurtz speaks at the Wall Street Journal Tech Live conference in Laguna Beach, California, on Oct. 21, 2019.Martina Albertazzi | Bloomberg | Getty Images

CrowdStrike shares dropped 6.3% after issuing weak earnings guidance as the company signaled ongoing pressure from its global IT outage that rattled businesses in July.

The cybersecurity software provider said it expects fiscal first-quarter earnings to range between 64 cents and 66 cents per share, versus the average Factset estimate of 95 cents. CrowdStrike is projecting earnings for the year to range between $3.33 and $3.45 per share, excluding items. That fell short $4.42 expected by analysts polled by LSEG.

For the fiscal fourth quarter, CrowdStrike posted a net loss of $92.3 million, or 37 cents per share, versus net income of $53.7 million, or 22 cents per share, in the year-ago period. The company also reported $21 million in costs from incident-related expenses and $49.9 million of tax expenses connected to acquisitions.

The company also said it anticipates another $73 million in expenses for the first quarter resulting from its July update that spurred a global information technology outage, grounded flights and disrupted businesses. CrowdStrike projects an additional $43 million in costs due to some deal packages offered in its wake.

The outage has also weighed on free cash flow margins, which CrowdStrike said on a conference call with analysts Tuesday it expects to return to 30% or more in fiscal 2027.

Read more CNBC tech news

  • Standard Chartered still sees bitcoin hitting $500,000 despite recent selloff
  • Snowflake surges 8% on earnings beat as company expands AI push
  • Stripe’s valuation climbs to $91.5 billion in secondary stock offer
  • Amazon touts its first quantum computing chip a week after Microsoft’s unveiling

Many on Wall Street expect headwinds from the July issue to start abating in the new fiscal year, with Bernstein’s Peter Weed expecting a pick up in CrowdStrike net retention rate in the new fiscal year.

“Although FY26 guidance marked a conservative start to the year, in our view, we expect management is setting the stage for a return to a beat-and-raise cadence we saw before the outage,” wrote JPMorgan’s Brian Essex.

CrowdStrike’s disappointing guidance offset better-than-expected fiscal fourth-quarter results. The company posted adjusted earnings of $1.03 per share on $1.06 billion in revenue and said that revenue grew 25% from a year ago.

Founder and CEO George Kurtz called the company a “comeback story” on the conference call.

“I’m extremely proud of the engagement we’ve had with customers, partners, prospects in the market navigating a year that tested CrowdStrike,” he said. “Q4 showcases the fruits of our labors, giving me strong conviction in our AI-native, single platform, excellent execution, and accelerating market opportunity.”

Correction: A prior version of this story had the incorrect figure for net loss.

Don’t miss these insights from CNBC PRO

  • Why Tesla’s stock is unraveling and what happens next, according to Barclays
  • How to produce income from Nvidia while waiting for a rebound
  • Hedge funds are buying more of these ‘rising star’ stocks, according to Goldman
  • These S&P 500 stocks are deeply oversold and may be due for a rebound


Ad

Somaderm

SomaDerm, SomaDerm CBD, SomaDerm AWE (by New U Life).

Somaderm Gel is an advanced scientific formulation created to support your body’s natural growth hormone production. Somaderm is based on the latest research and technology in the field of nutritional supplements and is designed to help you feel and look your best.